To the content
5 . 2021

Liver gene expression in normal and obese rats received resveratrol and L-carnitine

Abstract

The use of nutraceuticals with anti-inflammatory and hypolipidemic activity in the composition of foods for special dietary uses and dietary supplements is one of the effective methods of dietary therapy of alimentary obesity and related diseases.

The aim was to study the effect of the combined intake of resveratrol and L-carnitine (RC) on the expression of genes responsible for the metabolism of carbohydrates, fats and inflammatory reactions in the liver and kidneys of rats in normal conditions and with diet-induced obesity.

Material and methods. Male Wistar rats received for 63 days a standard balanced diet or a high-fat-high-carbohydrate diet (HFCD) with an excess of total fat (30%) and fructose (20% solution instead of drinking water), or the same diets supplemented with RC in a low (25 mg/kg body weight as resveratrol and 300 mg/kg as L-carnitine) or high (50 and 600 mg/kg body weight, respectively) doses. The expression of genes (Khk, Gck, Pklr, Acaca, Acacb, Fasn, Scd, Srebfl, Mlxipl, Ppara, Pparg, Actb, Gapdh) in liver cells was studied by the method of real-time reverse transcription polymerase chain reaction (RT-PCR). The distribution of tyrosine aminotransferase (TAT), nuclear factor erythroid 2-related factor 2 (NRF-2) and intercellular adhesion molecule type 2 (ICAM-2) in the liver and kidneys was assessed by confocal laser microscopy and immunohistochemistry.

Results. Increased expression of Fasn (fatty acid synthase) in rats treated with high-fat high-carbohydrate diet (HFCD) decreased under RC intake. RC consumption caused a decrease in the number of TAT-, NRF-2- and ICAM-2-positive cells in the liver of rats treated with HFCD, but had the opposite effect in the kidneys. The consumption of RC at the low dose by rats fed HFCD caused changes in the expression profiles of the studied marker genes, indicating a possible hypolipidemic effect. However, observed increased expression of lipogenic genes in the liver and elevated level of NRF-2 and ICAM-2 in kidney against the background of consumption of RC with the standard balanced diet cannot be assessed as unambiguously positive.

Conclusion. Thus, possible negative effects caused, most likely, by the interaction of nutraceuticals with various mechanisms of action should be taken into account when developing formulations of dietary supplements and foods for special dietary uses for dietary therapy of obesity.

Keywords:obesity, rats, resveratrol, carnitine, gene expression, polymerase chain reaction, confocal microscopy

Funding. The research was funded by Russian Science Foundation (grant № 17-16-01043 “Search for effector units of metabolism regulated by alimentary factors in obesity for the development of innovative specialized food”).

Conflict of interest. The authors declare no conflict of interests.

For citation: Trusov N.V., Semin M.O., Shipelin V.A., Apryatin S.A., Gmoshinski I.V. Liver gene expression in normal and obese rats received resveratrol and L-carnitine. Voprosy pitaniia [Problems of Nutrition]. 2021; 90 (5): 25-37. DOI: https://doi.org/10.33029/0042-8833-2021-90-5-25-37 (in Russian)

References

1. Rauf A., Imran M., Suleria H.A.R., Ahmad B., Peters D.G., Mubarak M.S. A comprehensive review of the health perspectives of resveratrol. Food Funct. 2017; 8 (12): 4284–305. DOI: https://doi.org/10.1039/c7fo01300k

2. Malaguarnera L. Influence of resveratrol on the immune response. Nutrients. 2019; 11 (5): 946. DOI: https://doi.org/10.3390/nu11050946

3. Longo N., Frigeni M., Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta Mol Cell Res. 2016; 1863 (10): 2422–35. DOI: https://doi.org/10.1016/j.bbamcr.2016.01.023

4. Panchal S.K., Poudyal H., Ward L.C., Waanders J., Brown L. Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats. Food Funct. 2015; 6 (8): 2496–506. DOI: https://doi.org/10.1039/c5fo00480b

5. Wang S., Xu J., Zheng J., Zhang X., Shao J., Zhao L., Hao J. Anti-inflammatory and antioxidant effects of acetyl-l-carnitine on atherosclerotic rats. Med Sci Monit. 2020; 26: e920250. DOI: https://doi.org/10.12659/MSM.920250

6. Traina G. The neurobiology of acetyl-L-carnitine. Front Biosci (Landmark Ed). 2016; 21: 1314–29. DOI: https://doi.org/10.2741/4459

7. Ma S., Feng J., Zhang R., Chen J., Han D., Li X., et al. SIRT1 Activation by resveratrol alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy mice. Oxid Med Cell Longev. 2017; 2017: 4602715. DOI: https://doi.org/10.1155/2017/4602715

8. Saqib U., Kelley T.T., Panguluri S.K., Liu D., Savai R., Baig M.S., et al. Polypharmacology or promiscuity? Structural interactions of resveratrol with its bandwagon of targets. Front Pharmacol. 2018; 9: 1201. DOI: https://doi.org/10.3389/fphar.2018.01201

9. Misawa T., Saitoh T., Kozaki T., Park S., Takahama M., Akira S. Resveratrol inhibits the acetylated-tubulin-mediated assembly of the NLRP3-inflammasome. Int Immunol. 2015; 27: 425–34. DOI: https://doi.org/10.1093/intimm/dxv018

10. Guide for the care and use of laboratory animals. 8th ed. In: Committee for the Update of the Guide for the Care and Use of Laboratory Animals; Institute for Laboratory Animal Research (ILAR); Division on Earth and Life Studies (DELS); National Research Council of the national academies. Washington: The National Academies Press, 2011.

11. Shipelin V.A., Shumakova A.A., Semin M.O., Trusov N.V., Balakina A.S., Timonin A.N., et al. Influence of the L-carnitine and resveratrol complex on physiological, biochemical and morphological indicators of normal and obese rats. Voprosy pitaniia [Problems of Nutrition]. 2021; 90 (1): 15–32. DOI: https://doi.org/10.33029/0042-8833-2021-90-1-15-32 (in Russian)

12. Apryatin S.A., Shipelin V.A., Trusov N.V., Mzhelskaya K.V., Evstratova V.S., Kirbaeva N.V., et al. Comparative analysis of the influence of a high-fat/high-carbohydrate diet on the level of anxiety and neuromotor and cognitive functions in Wistar and DAT-KO rats. Physiol Rep. 2019; 7 (4): e13987. DOI: https://doi.org/10.14814/phy2.13987

13. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001; 25 (4): 402–8. DOI: https://doi.org/10.1006/meth.2001.1262

14. Botros M., Sikaris K.A. The De Ritis ratio: the test of time. Clin Biochem Rev. 2013; 34: 117–30.

15. Mzhel’skaya K.V., Trusov N.V., Apryatin S.A., Soto C.J., Gmoshinski I.V., Tutel’yan V.A. Effect of quercetin on the expression of the carbohydrate and lipid metabolism genes in the liver of rats with genetic and alimentary obesity. Voprosy pitaniia [Problems of Nutrition]. 2019; 88 (2): 6–16. DOI: 10.24411/0042-8833-2019-10012 (in Russian)

16. Buqué X., Martínez M.J., Cano A., Miquilena-Colina M.E., García-Monzón C., Aspichueta P., et al. A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. J Lipid Res. 2010; 51 (3): 500–13. DOI: https://doi.org/10.1194/jlr.M001966

17. Vilà L., Rebollo A., Ađalsteisson G.S., Alegret M., Merlos M., Roglans N., et al. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. Toxicol Appl Pharmacol. 2011; 251 (1): 32–40. DOI: https://doi.org/10.1016/j.taap.2010.11.011

18. Rutledge A.C., Khosrow A. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev. 2007; 65 (6 pt 2): S13–23. DOI: https://doi.org/10.1111/j.1753-4887.2007.tb00322.x

19. Jiang F., Zhang Z., Zhang Y., Pan X., Yu L., Liu S. L-Carnitine ameliorates cancer cachexia in mice partly via the carnitine palmitoyltransferase-associated PPAR-γ signaling pathway. Oncol Res Treat. 2015; 38 (10): 511–6. DOI: https://doi.org/10.1159/000439550

20. Liu L., Zhang D.M., Wang M.X., Fan C.Y., Zhou F., Wang S.J., et al. The adverse effects of long-term l-carnitine supplementation on liver and kidney function in rats. Hum Exp Toxicol. 2015; 34 (11): 1148–61. DOI: https://doi.org/10.1177/0960327115571767

21. Dong W., Wang X., Bi S., Pan Z., Liu S., et al. Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins. Int J Mol Med. 2014; 33 (5): 1161–8. DOI: https://doi.org/10.3892/ijmm.2014.1680

22. Ardid-Ruiz A., Ibars M., Mena P., Del Rio D., Muguerza B., Arola L., et al. Resveratrol treatment enhances the cellular response to leptin by increasing OBRb content in palmitate-induced steatotic HepG2 cells. Int J Mol Sci. 2019; 20 (24): 6282. DOI: https://doi.org/10.3390/ijms20246282

23. Lin H.C., Chen Y.F., Hsu W.H., Yang C.W., Kao C.H., Tsai T.F. Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. Cancer Prev Res. (Phila). 2012; 5 (7): 952–62. DOI: https://doi.org/10.1158/1940-6207.CAPR-12-0001

24. Mendes K.L., de Pinho L., Andrade J.M., Paraíso A.F., Lula J.F., Macedo S.M., et al. Distinct metabolic effects of resveratrol on lipogenesis markers in mice adipose tissue treated with high-polyunsaturated fat and high-protein diets. Life Sci. 2016; 153: 66–73. DOI: https://doi.org/10.1016/j.lfs.2016.04.014

25. Volkow N.D., Wang G.J., Baler R.D. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2011; 15 (1): 37–46. DOI: https://doi.org/10.1016/j.tics.2010.11.001

26. Johansson M., Johansson N., Lund B.O. Xenobiotics and the glucocorticoid receptor: additive antagonistic effects on tyrosine aminotransferase activity in rat hepatoma cells. Basic Clin Pharmacol Toxicol. 2005; 96 (4): 309–15. DOI: https://doi.org/10.1111/j.1742-7843.2005.pto960406.x

27. Schwager J., Richard N., Widmer F., Raederstor D. Resveratrol distinctively modulates the inflammatory profiles of immune and endothelial cells. BMC Complement Altern Med. 2017; 17 (1): 309. DOI: https://doi.org/10.1186/s12906-017-1823-z

28. Ahmed S.M., Luo L., Namani A., Wang X.J., Tang X. Nrf2 signaling pathway: pivotal roles in inflammation. Biochim Biophys Acta Mol Basis Dis. 2017; 1863 (2): 585–97. DOI: https://doi.org/10.1016/j.bbadis.2016.11.005

29. Trusov N.V., Shipelin V.A., Mzhelskaya K.V., Shumakova A.A., Timonin A.N., Riger N.A., et al. Effect of resveratrol on behavioral, biochemical and immunological parameters of DBA/2J and tetrahybrid DBCB mice receiving diet with excess fat and fructose. J Nutr Biochem. 2021; 8: 108527. DOI: https://doi.org/10.1016/j.jnutbio.2020.108527

30. Trusov N.V., Mzhel’skaya K.V., Shipelin V.A., Shumakova A.A., Timonin A.N., Riger N.A., et al. The influence of l-carnitine on the immunological, integral and biochemical parameters of mice receiving a diet with excess of fat and fructose. Rossiyskiy fiziologicheskiy zhurnal imeni I.M. Sechenova [Russian Journal of Physiology named after I.M. Sechenov]. 2019; 105 (5): 619–33. DOI: https://doi.org/10.1134/S0869813919050121 (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

SCImago Journal & Country Rank
Scopus CiteScore
CHIEF EDITOR
CHIEF EDITOR
Viktor A. Tutelyan
Full Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Professor, Scientific Director of the Federal Research Centre of Nutrition, Biotechnology and Food Safety (Moscow, Russia)

Journals of «GEOTAR-Media»